The global lixisenatide market is anticipated to grow at a considerable CAGR during the forecast period (2024-2031). The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers, and acquisitions, geographical expansions, and product innovations to remain competitive in the market. For instance, in June 2021, Novo Nordisk received US Food and Drug Administration (FDA) approval of Wegovy (semaglutide) injection for chronic weight management in adults with obesity with one weight-related condition such as high blood pressure, type-2 diabetes, or cholesterol. Furthermore, in June 2019, Novo Nordisk has received US Food and Drug Administration Approval of expanded use of Victoza injection to lower the blood sugar along with diet and exercise in children and adolescents aged 10-17 years with type-2 diabetes. The Victoza also plays a major role in reducing the risk of cardiovascular events such as heart attacks, stroke, or deaths in adults with type-2 diabetes mellitus with known heart disease. Thus, such approvals from the US FDA are anticipated to drive the growth of the global lixisenatide market during the forecast period.
Get Free Sample link @ https://www.omrglobal.com/request-sample/lixisenatide-market
The rise in the prevalence of obesity due to urbanization is one of the major factors driving the global lixisenatide market. According to the data published by World Health Organization (WHO) in 2021, 55% of the world population lives in urban areas, and is expected to rise to 68% by 2050. Approximately 40% of urban dwellers have no access to sanitization services and adequate drinking water further leading to an increase in the burden of non communicable diseases such as asthma, diabetes associated with obesity. Moreover, physical inactivity in the cities lacking transit and walking infrastructure are anticipated to increase the prevalence of obesity among the population, further driving the growth of the global lixisenatide market during the forecast period.
Full report of Lixisenatide Market available @ https://www.omrglobal.com/industry-reports/lixisenatide-market
Market Coverage
Segment Covered-
- By Type
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- Zealand Pharma, Sanofi Aventis U.S Llc, Elli Lily & Co, GlaxoSmithKline Plc. more among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Lixisenatide Market Report Segment
By Type
- Tablet
- Liquid Injection
By Application
- Hospitals
- Clinic
- Medical Center
- Others
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/lixisenatide-market
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
